Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.

Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.

Item
http://www.wikidata.org/entity/Q41495990
Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients.Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.Recent advances in allograft vasculopathy.Donor-Specific Antibodies in Kidney Transplant Recipients.Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.The lack of Lazarus effect with proteasome inhibition.Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients.
P2860

Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.

Item
http://www.wikidata.org/entity/Q41495990
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bortezomib may stabilize pedia ...... h antibody-mediated rejection.
@en
type
label
Bortezomib may stabilize pedia ...... h antibody-mediated rejection.
@en
prefLabel
Bortezomib may stabilize pedia ...... h antibody-mediated rejection.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P932
P356
P1433
P1476
Bortezomib may stabilize pedia ...... h antibody-mediated rejection.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P932